Perrigo Company plc Machinery and Equipment, Gross
Perrigo Company plc (PRGO) had Machinery and Equipment, Gross of $1.19 billion as of 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization › Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization
us-gaap:MachineryAndEquipmentGross · last filed 2022-03-01
- 2021-12-31: Machinery and Equipment, Gross $1.19B.
- 2020-12-31: Machinery and Equipment, Gross $1.16B; Machinery and Equipment, Gross as first filed $1.34B.
- 2019-12-31: Machinery and Equipment, Gross $1.20B.
- 2018-12-31: Machinery and Equipment, Gross $1.08B.
| Period end | Machinery and Equipment, Gross | Machinery and Equipment, Gross as first filed |
|---|---|---|
| 2021-12-31 | $1.19B 10-K · filed 2022-03-01 | |
| 2020-12-31 | $1.16B 10-K · filed 2022-03-01 | $1.34B 10-K · filed 2021-03-01 |
| 2019-12-31 | $1.20B 10-K · filed 2021-03-01 | |
| 2018-12-31 | $1.08B 10-K · filed 2020-02-27 | |
| 2017-12-31 | $1.08B 10-K · filed 2019-02-27 | |
| 2016-12-31 | $1.09B 10-K · filed 2018-03-01 | |
| 2015-12-31 | $1.10B 10-K · filed 2018-03-01 | |
| 2015-06-27 | $1.09B 10-K · filed 2017-05-22 | |
| 2014-06-28 | $1.00B 10-KT · filed 2016-02-25 | |
| 2013-06-29 | $863.70M 10-K · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |